Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer.

PURPOSE To compare three-dimensional (3D) and four-dimensional (4D) computed tomography (CT)-based treatment plans for proton therapy or intensity-modulated radiation therapy (IMRT) for esophageal cancer in terms of doses to the lung, heart, and spinal cord and variations in target coverage and normal tissue sparing. METHODS AND MATERIALS The IMRT and proton plans for 15 patients with distal esophageal cancer were designed from the 3D average CT scans and then recalculated on 10 4D CT data sets. Dosimetric data were compared for tumor coverage and normal tissue sparing. RESULTS Compared with IMRT, median lung volumes exposed to 5, 10, and 20 Gy and mean lung dose were reduced by 35.6%, 20.5%, 5.8%, and 5.1 Gy for a two-beam proton plan and by 17.4%, 8.4%, 5%, and 2.9 Gy for a three-beam proton plan. The greater lung sparing in the two-beam proton plan was achieved at the expense of less conformity to the target (conformity index [CI], 1.99) and greater irradiation of the heart (heart-V40, 41.8%) compared with the IMRT plan(CI, 1.55, heart-V40, 35.7%) or the three-beam proton plan (CI, 1.46, heart-V40, 27.7%). Target coverage differed by more than 2% between the 3D and 4D plans for patients with substantial diaphragm motion in the three-beam proton and IMRT plans. The difference in spinal cord maximum dose between 3D and 4D plans could exceed 5 Gy for the proton plans partly owing to variations in stomach gas filling. CONCLUSIONS Proton therapy provided significantly better sparing of lung than did IMRT. Diaphragm motion and stomach gas-filling must be considered in evaluating target coverage and cord doses.

[1]  Helen H Liu,et al.  Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. , 2006, International journal of radiation oncology, biology, physics.

[2]  D. Lefkopoulos,et al.  Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes? , 2005, International journal of radiation oncology, biology, physics.

[3]  K. Kagei,et al.  Clinical results of proton beam therapy for cancer of the esophagus. , 2005, International journal of radiation oncology, biology, physics.

[4]  R. Mohan,et al.  Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. , 2003, International journal of radiation oncology, biology, physics.

[5]  Thomas Guerrero,et al.  Reduction of pulmonary compliance found with high-resolution computed tomography in irradiated mice. , 2007, International journal of radiation oncology, biology, physics.

[6]  Patrice Jalade,et al.  Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Joe Y. Chang,et al.  4D Proton treatment planning strategy for mobile lung tumors. , 2007, International journal of radiation oncology, biology, physics.

[8]  Daniel W. Miller,et al.  Methodologies and tools for proton beam design for lung tumors. , 2001, International journal of radiation oncology, biology, physics.

[9]  A R Smith,et al.  Intensity-modulated conformal radiation therapy and 3-dimensional treatment planning will significantly reduce the need for therapeutic approaches with particles such as protons. , 1999, Medical physics.

[10]  Joe Y. Chang,et al.  The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Radhe Mohan,et al.  Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[12]  E. Pedroni,et al.  The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. , 1995, Medical physics.

[13]  Radhe Mohan,et al.  Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm , 2007, Physics in medicine and biology.

[14]  L. Marks,et al.  Cardiac toxicity following thoracic radiation. , 2005, Seminars in oncology.

[15]  D P Dearnaley,et al.  A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  K. Chu,et al.  Predictive Factors for Postoperative Pulmonary Complications and Mortality After Esophagectomy for Cancer , 2004, Annals of surgery.

[17]  Eros Pedroni,et al.  Treating Cancer with Protons , 2002 .

[18]  U. Isacsson,et al.  Comparative treatment planning between proton and x-ray therapy in esophageal cancer. , 1998, International journal of radiation oncology, biology, physics.

[19]  M. Ferguson,et al.  Induction therapy does not increase surgical morbidity after esophagectomy for cancer. , 2004, The Annals of thoracic surgery.

[20]  Eike Rietzel,et al.  Four-dimensional proton treatment planning for lung tumors. , 2006, International journal of radiation oncology, biology, physics.

[21]  Zhongxing Liao,et al.  Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). , 2005, International journal of radiation oncology, biology, physics.

[22]  H. Tsujii,et al.  Proton beam therapy with high-dose irradiation for superficial and advanced esophageal carcinomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  Radhe Mohan,et al.  Incorporating partial shining effects in proton pencil-beam dose calculation , 2008, Physics in medicine and biology.

[24]  Joe Y. Chang,et al.  Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.